Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
Titel:
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
Auteur:
Boeck, S. Hoehler, T. Seipelt, G. Mahlberg, R. Wein, A. Hochhaus, A. Boeck, H.-P. Schmid, B. Kettner, E. Stauch, M. Lordick, F. Ko, Y. Geissler, M. Schoppmeyer, K. Kojouharoff, G. Golf, A. Neugebauer, S. Heinemann, V.